Please try another search
For the three months ended 31 March 2019, GLG PharmaSA revenues was not reported. Net loss decreased 86% toPLN41K. Lower net loss reflects Salaries decrease fromPLN68K (expense) to PLN0K, Other Expense decrease fromPLN13K (expense) to PLN0K, Material Cost decrease fromPLN4K (expense) to PLN0K.
Period Ending: | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | -0.04 | -0.52 | -0.12 | -0.34 |
Operating Income | -0.04 | -0.7 | -0.2 | -0.42 |
Net Income | -0.04 | -0.72 | -0.2 | -0.42 |
Period Ending: | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Total Assets | 17.46 | 17.54 | 17.51 | 16.97 |
Total Liabilities | 3.41 | 3.45 | 3.33 | 2.59 |
Total Equity | 14.05 | 14.09 | 14.18 | 14.38 |
Period Ending: | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -0.14 | -0.78 | -0.81 | -0.94 |
Cash From Investing Activities | 0 | 0 | 0 | |
Cash From Financing Activities | 0.07 | 0.28 | 0.24 | 0.18 |
Net Change in Cash | -0.07 | -0.49 | -0.57 | -0.76 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review